tert-Butyl (4-methylthiazol-2-yl)carbamate

Catalog No. :
ACCQXW807
CAS No. :
848472-44-6
Molecular Formula :
C9H14N2O2S
Molecular Weight :
214.29

IUPAC Name:tert-butyl (4-methylthiazol-2-yl)carbamate

tert-Butyl (4-methylthiazol-2-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$171.00Login to see priceIn stockIn stock
25g97%$692.00Login to see priceInquiryIn stock
100g97%$2329.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (4-methylthiazol-2-yl)carbamate
IUPAC Nametert-butyl (4-methylthiazol-2-yl)carbamate
MDL No.MFCD11501911
Molecular FormulaC9H14N2O2S
Molecular Weight214.29
SMILESO=C(OC(C)(C)C)NC1=NC(C)=CS1
InChI KeyJGBZPLSFZVKDDV-UHFFFAOYSA-N
SynonymCarbamic acid, N-(4-methyl-2-thiazolyl)-, 1,1-dimethylethyl ester;tert-butyl 4-Methylthiazol-2-ylcarbaMate;2-methyl-2-propanyl (4-methyl-1,3-thiazol-2-yl)carbamate;100420;tert-butyl N-(4-methyl-1,3-thiazol-2-yl)carbamate;2-(Boc-amino)-4-methylthiazole
CAS No.848472-44-6
PubChem CID45117839

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACCQXW807 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYVPK267 route compound structure diagram
    ACYVPK2671603-91-4 In Stock
  4. Then
  5. ACCQXW807 route product structure diagram
    ACCQXW807848472-44-6 In Stock
Inquiry

2. ACCQXW807 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRXTU587 route compound structure diagram
    ACRXTU587268551-65-1 In Stock
  4. Then
  5. ACCQXW807 route product structure diagram
    ACCQXW807848472-44-6 In Stock
Inquiry

Comments (0)